Southern Acids (M) Bhd (XKLS:5134) Stock Based Compensation: RM0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:5134 Southern Acids (M) Bhd XKLS:5134
70 GF Score
Price RM3.06
GF Value RM2.88
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Southern Acids (M) Bhd Stock Based Compensation?

Southern Acids (M) Bhd XKLS:5134 -0.33% 70 Stock Based Compensation is RM0.0 Mil as of Mar. 2026. GuruFocus rates XKLS:5134 with a GF Score™ of 70/100 and a GF Value™ of RM2.88 (Fairly Valued). The stock has 4 warning signs investors should review.

Southern Acids (M) Bhd's Stock Based Compensation for the three months ended in Mar. 2026 was RM0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.0 Mil.

Southern Acids (M) Bhd Stock Based Compensation Related Terms

Southern Acids (M) Bhd Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Southern Acids (M) Bhd's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Southern Acids (M) Bhd Stock Based Compensation Chart

Southern Acids (M) Bhd Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Southern Acids (M) Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKLS:5134
70GF Score
Southern Acids (M) Bhd XKLS:5134
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Southern Acids (M) Bhd Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.0 Mil.

What does a Stock Based Compensation of RM0.0 Mil mean?
Southern Acids (M) Bhd (XKLS:5134) has a Stock Based Compensation of RM0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Southern Acids (M) Bhd and its competitors.
Is Southern Acids (M) Bhd's Stock Based Compensation too high?
Southern Acids (M) Bhd's current Stock Based Compensation is RM0.0 Mil. Overall, Southern Acids (M) Bhd has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's Stock Based Compensation compare to HON and MMM?
Southern Acids (M) Bhd's Stock Based Compensation of RM0.0 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Conglomerates company?
A good Stock Based Compensation depends on the Conglomerates industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Southern Acids (M) Bhd and its competitors. Southern Acids (M) Bhd's current Stock Based Compensation is RM0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.88, compared to a current price of RM3.06 — trading 6.3% above its estimated fair value. The current Stock Based Compensation is RM0.0 Mil. Southern Acids (M) Bhd's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current Stock Based Compensation is RM0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?

Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued. The current stock price of RM3.06 is trading 6.3% above its estimated GF Value™ of RM2.88. GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.

Key valuation signals for XKLS:5134:

  • Stock Based Compensation: RM0.0 Mil
  • GF Value™: RM2.88 vs. price of RM3.06 (6.3% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Southern Acids (M) Bhd Business Description

Address No. 8, Jalan Batu Tiga Lama, Level 29, Centro Tower, Klang, SGR, MYS, 41300
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
70GF Score

Get the complete analysis for XKLS:5134

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.06
Price
RM2.88
GF Value